IBKR (IBKR)

$113.1B
Market Cap
30.0
P/E Ratio
1.25
Beta
0.47%
Dividend Yield
Piotroski 4/9Altman Z 0.7 DistressBeneish M -2.32 Clean

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9, Altman Z 0.7.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics reveal a distinct capital efficiency profile where an ROIC of 15.4% suggests robust value generation, yet the DuPont decomposition indicates this return is driven almost entirely by high financial leverage rather than operational productivity or margin expansion; specifically, equity turnover sits at just 0.05x while margins remain healthy at 9.6%. Credit risk metrics present a contradictory signal: an Altman Z-Score of 0.7 flags potential distress territory despite the company's pristine Beneish M-Score of -2.32 and moderate Piotroski F-Score of 4/9, suggesting management earnings quality appears intact but solvency buffers are thin relative to industry norms. This structural reliance on leverage creates a scenario where equity returns are amplified by debt magnification rather than organic asset growth.

Valuation metrics currently reflect aggressive growth expectations that may not align with the underlying operational velocity; trading at 30.0x forward earnings, the stock commands a premium significantly above typical utility-like multiples for firms with such low asset turnover. While the DCF model implies a fair value of $1,258 based on assumed growth trajectories, this target price assumes execution capabilities consistent with high-growth tech peers rather than a mature financial intermediary. The market appears to be pricing in sustained acceleration that contrasts sharply with the reported 9.7% revenue growth and minimal asset efficiency, creating a divergence between current valuation premiums and fundamental operating characteristics.

Risk assessment is complicated by divergent data points; while insider activity shows substantial net selling of over $30 million within the last ninety days, potentially signaling management caution regarding near-term catalysts or liquidity needs, the low Beneish M-Score mitigates concerns about aggressive accounting manipulation. The combination of a distress-level Altman Z-Score and significant insider outflows warrants scrutiny regarding capital structure sustainability despite strong gross margins nearing 90%. Investors must weigh whether the high leverage driving ROE is a temporary strategic phase or an inherent risk that could compress equity value if revenue growth fails to meet the elevated DCF assumptions embedded in current pricing.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$1537$1127$883
3%$1800$1258$959
4%$2196$1433$1054

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $1258 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
0.7
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.32
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

89.8%
Gross Margin
9.6%
Net Margin
15.4%
ROIC
+9.7%
Revenue Growth (YoY)
+30.3%
Earnings Growth (YoY)
15.7B
Free Cash Flow
1%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

9.6%
Net Profit Margin
NI ÷ Revenue
×
0.05x
Asset Turnover
Revenue ÷ Assets
×
9.93x
Equity Multiplier
Assets ÷ Equity
=
4.8%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

8.93x
Debt / Equity
1.13x
Current Ratio
2.1x
Interest Coverage
14.56%
FCF Yield
9.1B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$31M
Net Selling
1
Buy Transactions
2
Sale Transactions
2026-03-02CONKLING LORI ABuy$5,391
2026-01-27NEMSER EARL HSold 2/7 qtrsSale$12M
2026-01-23NEMSER EARL HSold 2/7 qtrsSale$19M
2025-12-31GALIK MILANGrant$25,017
2025-12-31GALIK MILANGrant$25,017

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✗ Miss
Est: $0.48
Act: $0.47
-2.7%
Q3
✓ Beat
Est: $0.47
Act: $0.51
+8.8%
Q2
✓ Beat
Est: $0.54
Act: $0.57
+6.1%
Q1
✓ Beat
Est: $0.59
Act: $0.65
+11.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

24.3
Forward P/E
PEG Ratio
5.52
Price/Book
5M
Avg Volume
$79.18
52W High
$32.82
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$4.5B
Tracked Passive Exposure
8
ETFs Holding IBKR
0.07%
Avg Weight in ETFs
$6.7T
Total ETF AUM

When investors buy or sell ETFs like XLF or VFH, the fund manager is mechanically forced to buy or sell IBKR shares regardless of IBKR's individual fundamentals. We estimate $4.5B of passive capital is structurally linked to IBKR through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in IBKR to visualize passive redemption contagion across ETFs and collateral stocks.

IBKR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
IBKREpicenterVTIETFVOOETFIVVETFNVDALow RiskAAPLLow RiskBRK.BUnknownJPMHigh RiskJPMHigh Risk
IBKR Price Drop (%)0

If IBKR (IBKR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA Corp. (NVDA) as the most exposed collateral stock, sharing 2 ETFs with IBKR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 31 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

IBKR Ownership Dynamics

Ticker
IBKR

Float lock-up computed from 31 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

IBKR Capital Efficiency

How efficiently does IBKR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$15.7B
EBITDA
$9.1B
FCF Conversion
173%
Reinvestment Rate
-73%
173% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

IBKR converts 173% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-146,301$85.12$536,341.12
2026-05-136,500$84.59$549,835
2026-05-1116,782$84.42$1.4M
2026-05-08529$83.71$44,282.59
2026-05-052,135$81.72$174,472.2
2026-05-0499$80.46$7,965.54
2026-04-294$77.49$309.96
2026-04-271,695$76.62$129,870.9
2026-04-24853$75.90$64,742.7
2026-04-2212,211$79.62$972,239.82
2026-04-2112,340$81.25$1.0M
2026-04-20307$81.71$25,084.97
2026-04-1795$79.38$7,541.1
2026-04-166$79.69$478.14
2026-04-153$77.10$231.3
2026-04-141$74.55$74.55
2026-04-1312,408$71.21$883,573.68
2026-04-1013,242$71.93$952,497.06
2026-04-081,092$68.11$74,376.12
2026-04-0177$67.07$5,164.39
2026-03-312,420$63.69$154,129.8
2026-03-279$66.20$595.8
2026-03-2545$66.12$2,975.4
2026-03-2310$65.47$654.7
2026-03-201,384$67.69$93,682.96
2026-03-1680$66.19$5,295.2
2026-03-13714$66.92$47,780.88
2026-03-0520$69.15$1,383
2026-02-23800$74.40$59,520
2026-02-205,453$73.99$403,467.47

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare IBKR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.